Mallon Mark 4
4 · NEOGENOMICS INC · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-03-01+142,457→ 368,051 total - Award
Stock Option (Right to Buy)
2022-03-01+347,777→ 347,777 totalExercise: $21.41Exp: 2029-03-01→ Common Stock (347,777 underlying)
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (3)
- [F1]On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date.